Announcements

ReACH Assistant/ Associate/Professor Opening

Please visit our Job Opportunities page for more information about this exciting opportunity! 

ReACH Center Population Health Postdoctoral Fellowship

With funding from the UT System Collaborative on Population Health Innovation and Improvement and the Center for Research to Advance Community Health (ReACH), UT Health San Antonio is creating a new 2-year post-doctoral fellowship in population health. Eligible applicants are individuals who have received a doctoral degree and who are pursuing additional research and training in order to have better skills to pursue a career in academia, research or any other field.  For more information click here.

July 28th is World Hepatitis Day!

World Hepatits Day is July 28th and is an opportunity to lean more about the global burden of a group of infectious diseases known as hepatitis A, B, C, D and E which affect millions of people worldwide, causing both acute (short-term) and chronic (long-term) liver disease.  To learn more about the ReACH Center's work to influence real change for those with hepatitis C in Texas please visit stophepatitisC.com

 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

Kate Aultman, PhD

Kate Aultman, PhD
Contact: 

Kathryn Aultman, PhD
Director of Research
School of Health Professions
UT Health San Antonio
 
UT Health San Antonio
7703 Floyd Curl Drive
MSC: 6243
San Antonio, TX 78229
Phone: (210) 567-4845
Fax: (210) 567- 4828
Email: aultmank@uthscsa.edu

Kate Aultman, PhD is the Director of Research at the School of Health Professions at UT Health San Antonio.  She received her PhD in biochemistry at Louisiana State University in Baton Rouge and her undergraduate degree at the University of New Orleans.  Her early research focused on metabolism, nutrition and heart disease but quickly transitioned to infectious disease.  A Science and Diplomacy Fellowship from AAAS provided the opportunity to work in the US Agency for International Development and the WHO Global Program on AIDS to develop programs to slow the spread of the HIV/AIDS pandemic and to work at the country level to develop AIDS Control Programs.  After that she transitioned to the National Institute of Allergy and Infectious Diseases, where she continued her focus on global infectious diseases and specialized on the vector borne diseases, including malaria, dengue, Chagas’ disease and sleeping sickness.  Important projects included sequencing of the genome of Anopheles gambiae, the most important mosquito vector of malaria in Africa and establishing an industry-academic-government partnership to develop novel products for vector control.  In 2005 she was recruited to the Bill and Melinda Gates Foundation to establish a vector control program there.  The focus of that program included expanded support for product development, including discovery of novel modes of action; practical efforts to interrupt pathogen transmission at the local or national level; and expansion and evolution of the international regulatory and policy framework for evaluating vector control products.  Throughout her time at the NIH and the Gates Foundation she worked to develop early stage investigators and their projects. In her position at UT Health she continues that work.